Monitor the July 21 webinar for any clinical adoption or partnership announcements, but this filing alone provides no immediate trading catalyst. The company's $6M market cap and lack of revenue visibility suggest continued speculative risk.
Price Chart
Executive Summary
bioAffinity Technologies announced a July 21, 2026 webinar on veteran lung health screening, co-hosted with Philips, 4DMedical, and NAVREF. The event features clinical experts discussing CyPath Lung, mobile CT, and functional lung imaging. This is a routine educational/promotional event with no financial terms or material business developments disclosed.
Key Facts
- Webinar scheduled for July 21, 2026, hosted by NAVREF
- Panel includes Philips, bioAffinity (CyPath Lung), and 4DMedical
- CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy, 99% NPV in published trial
- No financial terms, partnership agreements, or revenue guidance disclosed
Financial Impact
No financial figures reported in the filing
Risk Factors
- No material financial or operational update — stock may remain range-bound
- Low institutional ownership and minimal analyst coverage limit price catalysts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-028823 |
| Exhibit: ex99-1.htm | 0001493152-26-028823 |
| Document: 0001493152-26-028823-index-headers.html | 0001493152-26-028823 |
| Document: 0001493152-26-028823-index.html | 0001493152-26-028823 |
| Document: 0001493152-26-028823.txt | 0001493152-26-028823 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | DEF 14A | $2.83 | awaiting T+60 | — | $2.96 (+4.59%) |
Oct 15, 2026 12d ago | 8-K | $3.96 | awaiting T+60 | — | $2.96 (−25.25%) |
Oct 13, 2026 14d ago | 8-K | $3.63 | awaiting T+60 | — | $2.96 (−18.34%) |
Oct 9, 2026 18d ago | 8-K | $3.90 | awaiting T+60 | — | $2.96 (+24.10%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (+37.35%) |
Oct 9, 2026 18d ago | 424B5 | $4.73 | awaiting T+60 | — | $2.96 (−37.35%) |
Oct 8, 2026 19d ago | 8-K | $5.64 | awaiting T+60 | — | $2.96 (−47.52%) |
Oct 6, 2026 21d ago | 8-K | $6.06 | awaiting T+60 | — | $2.96 (−51.16%) |
Sep 30, 2026 27d ago | 8-K | $6.56 | awaiting T+60 | — | $2.96 (−54.88%) |
Sep 22, 2026 5w ago | 8-K | $8.56 | awaiting T+60 | — | $2.96 (−65.40%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers